Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000942302-05-000054
Filing Date
2005-02-14
Accepted
2005-02-14 12:23:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 epix13ga1.txt SC 13G/A 12131
  Complete submission text file 0000942302-05-000054.txt   14133
Mailing Address 71 ROGERS ST CAMBRIDGE MA 02142-1118
Business Address 71 ROGERS ST CAMBRIDGE MA 02142-1118 6172506000
EPIX Pharmaceuticals, Inc. (Subject) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52847 | Film No.: 05605735
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 388 MARKET STREET SUITE 200 SAN FRANCISCO CA 94111
Business Address 388 MARKET STREET SUITE 200 SAN FRANCISCO CA 94111 4155912700
RS INVESTMENT MANAGEMENT CO LLC (Filed by) CIK: 0001085256 (see all company filings)

EIN.: 943321067
Type: SC 13G/A